New vaccine for terminal cancer is trialled
A trial has been launched in the UK to test a new vaccine for terminal cancer. The immunotherapy trial will examine whether a vaccine is effective in stimulating the body's own immune system to destroy cancer cells.
Two patients have already received the vaccine as part of the trial, which is expected to run for up to two years.
Immunotherapy is generating great interest in the cancer research community. In February, experts in the US announced they had seen "extraordinary" results in early trials involving terminally ill patients with blood cancer.
The UK trial - in Guildford and London - is for people with solid tumours and is recruiting those who have failed on previous types of cancer treatment.
GMB speaks to 35 -year-old Kelly Potter, who has stage four cervical cancer. Chemotherapy hasn't helped her but she says she is staying positive as she takes part in the trial.